FGFR3 Gene Mutations Associated With Human Skeletal Disorders Occur Rarely in Multiple Myeloma

This publication has 13 references indexed in Scilit:

• A Novel Chromosomal Translocation t(4; 14)(p16.3; q32) in Multiple Myeloma Involves the Fibroblast Growth-Factor Receptor 3 Gene
  Blood, 1997
• Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
  Nature Genetics, 1997
• FGFR activation in skeletal disorders: Too much of a good thing
  Trends in Genetics, 1997
• Profound Ligand-Independent Kinase Activation of Fibroblast Growth Factor Receptor 3 by the Activation Loop Mutation Responsible for a Lethal Skeletal Dysplasia, Thanatophoric Dysplasia Type II
  Molecular and Cellular Biology, 1996
• Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia
  Nature Genetics, 1996
• Fibroblast-growth-factor receptor mutations in human skeletal disorders
  Trends in Genetics, 1995
• Stop codon FGFR3 mutations in thanatophoric dwarfism type 1
  Nature Genetics, 1995
• Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3
  Nature Genetics, 1995
• Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia
  Published by Elsevier ,1994
• Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3.
  Proceedings of the National Academy of Sciences, 1991